RARA CRAFT DATABASE for FDA Medical Devices
510(k)K212954

FDA DEVICE FACTS

G-Tech Wireless Patch System (WPS)

G-Tech Medical

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJanuary 10, 2022PRODUCT CODEMYE

Indications for use

The G-Tech Wireless Patch System and the predicate device have the same indications for use and same intended population. Technology: The G-Tech WPS operates on the same fundamental principal as the predicate system by measuring myoelectrical activity with cutaneous electrodes at the abdominal skin surface. Technological improvements in the G-Tech WPS that improve on the predicate system have been evaluated to ensure that the safety and efficacy profile of the predicate device is maintained for the G-Tech Patch System. Electrical safety and electromagnetic compatibility (EMC): Electrical safety and EMC testing were conducted on the G-Tech Wireless Patch System. The G- Tech Wireless Patch System complies with the following standards

• IEC 60601-1:2005

• IE C 60601 -1-11:2015

• IE C 60601 -1-6:2010

• IE C 60601 -1- 2:2014

• ANS I C63.27 -2017 Biocompatibility: Th e biocompatibility of the G-Tech Patch System was assessed by evaluating the results of the testing recommended by ISO 10993- 1:2009, Biological evaluation of medical devices -- Part 1: Evaluation and testing within a risk management. The G-Tech Patch has been assessed to be compliant for contact with intact skin for up to 30 days. Software Verification and Validation Testing: The G-Tech Patch System uses software to acquire and process the myoelectrical signals and generate a report for the Physician. Software documentation for the G-Tech Patch System was developed in consideration of FDA's guidance documents, "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices" and “Content of Premarket Submissions for the Management of Cybersecurity in Medical Devices” and is provided. Mechanical Strength Testing: Mechanical Strength testing that includes wear adhesion test and tensile strength test are presented. Additionally, impact test, drop test and shock and vibration tests, conducted for compliance to 60101-1-11 that assesses requirements of medical electrical equipment for Home Healthcare, is presented. The testing demonstrates that the G-Tech Wireless Patch System device should perform as intended in the specified use conditions and maintain the safety profile of the predicate system. Bench Performance Study: Functional bench testing performed to demonstrate the performance and efficiency of the patch system and algorithms that calculate myoelectrical activity of the Stomach and Intestines are presented. Known signals that have realistic background, artifact and noise characteristics to the system were applied to the system both directly and through a phantom, to assess how the system will perform when the signals are real and not known a priori. The study demonstrated that the G-Tech Patches are reliable and provide consistent electrical measurement devices, and that the data processing algorithms are efficient engines for extracting rhythmic motor activity signals. Animal Study: Data from a study undertaken to compare simultaneous measurements between G-Tech Wireless Patches and multi-element electrodes sutured to serosal surfaces of stomach, small intestine, and colon of adolescent Yucatan mini-pigs is presented. The data demonstrate that the slow wave signals associated with the three major GI organs as observed with internal electrodes are detectable at the skin surface with the G-Tech Wireless Patches and have fidelity to the internally measured signals in frequency and spectral shape. Clinical Studies: G-Tech Medical has studied its technology under several non-significant risk IRB-approved studies and well-documented case histories. These studies have focused on understanding the measurement capabilities and potential clinical utility of the technology. The primary evidence includes simultaneous measurements between G-Tech Wireless Patches and antroduodenal and colonic manometry that demonstrates that the non-invasive patch system records signals that can be identified as being from the Stomach, Duodenum/Jejunum and Colon by the concordance with frequency and time, of spectral analysis of high-resolution manometry data. Similarly, concordance in frequency and time observed between G-Tech Wireless Patch measurements and Smart Pill measurements is presented that corroborates the findings from the manometry study. The supplemental evidence provided are four peer-reviewed publications listed below. Three of these demonstrate correlation between the G-Tech Wireless Patch Measurements and clinical markers of postoperative recovery in adult and pediatric populations. A fourth peer reviewed publication demonstrates reproducibility of the gastric and intestinal myoelectrical profile over multi-year periods and the sensitivity of the measurements to in external stimulus in specific examples.

1. Dua, M.M., Navalgund, A., Axelrod, S., Axelrod, L., Worth, P.J., Norton, J.A., Poultsides, G.A., Triadafilopoulos, G. and Visser, B.C., 2018. Monitoring gastric myoelectric activity after pancreaticoduodenectomy for diet “readiness”. American Journal of Physiology-Gastrointestinal and Liver Physiology, 315(5), pp. G743-G751.

2. Navalgund, A., Axelrod, S., Axelrod, L., Singhal, S., Tran, K., Legha, P., & Triadafilopoulos, G. (2019). Colon myoelectric activity measured after open abdominal surgery with a noninvasive wireless patch system predicts time to first flatus. Journal of Gastrointestinal Surgery, 23(5), 982-989.

3. Taylor, J.S., de Ruijter, V., Brewster, R., Navalgund, A., Axelrod, L., Axelrod, S., Dunn, J.C. and Wall, J.K., 2019. Cutaneous Patches to Monitor Myoelectric Activity of the Gastrointestinal Tract in Postoperative Pediatric Patients. Pediatric gastroenterology, hepatology & nutrition, 22(6), pp.518-526.

4. Axelrod, L., Axelrod, S., Navalgund, A. and Triadafilopoulos, G., 2020. Pilot Validation of a New Wireless Patch System as an Ambulatory, Noninvasive Tool That Measures Gut Myoelectrical Signals: Physiologic and Disease Correlations. Digestive Diseases and Sciences, pp.1-11.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 23, 2026